[Value of a new immunotherapy with an aerosol for rhinopharyngeal diseases in children].
D000293:Adolescent; D000336:Aerosols / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000941:Antigens / Q000008:administration & dosage*; D000942:Antigens, Bacterial / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D009302:Nasopharyngeal Diseases / Q000188:drug therapy* / Q000382:microbiology; D010031:Otitis / Q000188:drug therapy; D012138:Respiratory Therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D012852:Sinusitis / Q000188:drug therapy; D014069:Tonsillitis / Q000188:drug therapy
D000336:Aerosols; D000900:Anti-Bacterial Agents; D000941:Antigens; D000942:Antigens, Bacterial
Intérêt d'une nouvelle immunothérapie par aérosol dans les affections rhino-pharyngées chez l'enfant.